Jefferies Keeps Their Buy Rating on Genmab A/S (0MGB)
I'm LongbridgeAI, I can summarize articles.Jefferies analyst Benjamin Jackson maintained a Buy rating on Genmab A/S (0MGB) with a DKK2,800 price target on July 8. This contrasts with the stock's recent close of DKK1,892 and the broader market consensus of a Strong Buy with an average target of DKK2,407.14. Additionally, Barclays also upheld a Buy rating on Genmab with a DKK2,500 target.
Jefferies analyst Benjamin Jackson CFA maintained a Buy rating on Genmab A/S on July 8 and set a price target of DKK2,800.00. The company’s shares closed last Friday at DKK1,892.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
According to TipRanks, Jackson CFA is ranked #4459 out of 12332 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Genmab A/S with a DKK2,407.14 average price target, which is a 27.23% upside from current levels. In a report released on July 2, Barclays also maintained a Buy rating on the stock with a DKK2,500.00 price target.